MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, RKDA had -$3,983K decrease in cash & cash equivalents over the period. -$4,739K in free cash flow.

Cash Flow Overview

Change in Cash
-$3,983K
Free Cash flow
-$4,739K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Credit loss
    • Prepaid expenses and other curre...
    • Proceeds from sale of intangible...
    • Others
Negative Cash Flow Breakdown
    • Change in fair value of common s...
    • Net loss
    • Change in fair value of continge...
    • Others

Cash Flow
2025-12-31
Net loss
-2,339
Change in fair value of common stock warrant and option liabilities
2,384
Change in fair value of contingent consideration
-2,000
Depreciation
32
Lease amortization
122
Amortization of note receivable discount
-69
Gain on disposal of property and equipment
0
Gain on sale of intangible assets
750
Gain on receipt of above food ingredients, inc. common stock
1,067
Unrealized gain subsequent to receipt of above food ingredients, inc. common stock
1,237
Stock-based compensation
234
Credit loss
4,745
Write-down of inventories
0
Impairment of property and equipment
0
Write-down of non-controlling interest
0
Accounts receivable and other receivables
-165
Inventories
308
Prepaid expenses and other current assets
-775
Other noncurrent assets
50
Accounts payable and accrued expenses
-399
Amounts due to related parties
-30
Other current liabilities
-57
Operating lease payments
-122
Net cash used in operating activities
-4,739
Proceeds from sale of property and equipment
0
Proceeds from sale of investments
0
Proceeds from sale of intangible assets
750
Cash paid related to sale of goodwheat
0
Purchases of property and equipment
0
Net cash provided by investing activities
750
Proceeds from espp purchases
6
Net cash provided by financing activities
6
Net decrease in cash and cash equivalents
-3,983
Cash and cash equivalents - beginning of period
4,242
Cash and cash equivalents - end of period
259
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from sale ofintangible assets$750K Proceeds from espppurchases$6K Net cash provided byinvesting activities$750K Net cash provided byfinancing activities$6K Net decrease in cashand cash...-$3,983K Canceled cashflow$756K Credit loss$4,745K Prepaid expenses andother current assets-$775K Stock-based compensation$234K Accounts receivable andother receivables-$165K Lease amortization$122K Depreciation$32K Net cash used inoperating activities-$4,739K Canceled cashflow$6,073K Change in fair value ofcommon stock warrant...$2,384K Net loss-$2,339K Change in fair value ofcontingent consideration-$2,000K Unrealized gain subsequentto receipt of above...$1,237K Gain on receipt ofabove food...$1,067K Gain on sale ofintangible assets$750K Accounts payable andaccrued expenses-$399K Inventories$308K Operating lease payments-$122K Amortization of notereceivable discount-$69K Other currentliabilities-$57K Other noncurrentassets$50K Amounts due to relatedparties-$30K

Arcadia Biosciences, Inc. (RKDA)

Arcadia Biosciences, Inc. (RKDA)